Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Muscular Dystrophy Association and Coalition to Cure Calpain 3 Partner to Fund $300,000 Research Grant for Gene Therapy Development
Dec 17, 2024•over 1 year ago
Contract Type
partnership
New YorkBiotechnologyHealth CareNon ProfitDescription
The Muscular Dystrophy Association and Coalition to Cure Calpain 3 have announced a collaborative funding of a $300,000 research grant to support the work of Dr. Melissa Spencer, aimed at developing gene therapy for limb-girdle muscular dystrophy type 2A (LGMD2A/R1). This partnership underlines the importance of collaboration in advancing research for potential cures of neuromuscular diseases.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months